U.S. Transdermal Drug Delivery Systems Market Size & Outlook
Related Markets
U.S. transdermal drug delivery systems market highlights
- The U.S. transdermal drug delivery systems market generated a revenue of USD 32,686.9 million in 2023 and is expected to reach USD 69,830.9 million by 2030.
- The U.S. market is expected to grow at a CAGR of 11.5% from 2024 to 2030.
- In terms of segment, iontophoresis was the largest revenue generating technology in 2023.
- Mechanical arrays is the most lucrative technology segment registering the fastest growth during the forecast period.
Transdermal drug delivery systems market data book summary
| Market revenue in 2023 | USD 32,686.9 million |
| Market revenue in 2030 | USD 69,830.9 million |
| Growth rate | 11.5% (CAGR from 2024 to 2030) |
| Largest segment | Iontophoresis |
| Fastest growing segment | Mechanical arrays |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Electroporation, Radio Frequency, Iontophoresis, Microporation, Thermal, Mechanical arrays, Ultrasound |
| Key market players worldwide | Novartis AG ADR, Johnson & Johnson, Boehringer Ingelheim, Hisamitsu Pharmaceutical Co Inc, 3M Co, AbbVie Inc |
Other key industry trends
- In terms of revenue, U.S. accounted for 52.3% of the global transdermal drug delivery systems market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. transdermal drug delivery systems market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 12,496.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Transdermal Drug Delivery Systems Market Scope
Transdermal Drug Delivery Systems Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| 4P Therapeutics | View profile | 11-50 | Peachtree City, Georgia, United States, North America | http://www.4ptherapeutics.com/ |
| Grünenthal | View profile | 1001-5000 | Puteaux, Ile-de-France, France, Europe | https://www.grunenthal.fr |
| Mylan | View profile | 10001+ | https://www.mylan.in/ | |
| Hisamitsu Pharmaceutical Co Inc | View profile | 3682 | 408 Tashiro Daikan-machi, Tosu, Saga, Japan, 841-0017 | http://www.hisamitsu.co.jp |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| 3M Co | View profile | 85000 | 3M Center, St. Paul, MN, United States, 55144 | https://www.3m.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
U.S. transdermal drug delivery systems market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to transdermal drug delivery systems market will help companies and investors design strategic landscapes.
Iontophoresis was the largest segment with a revenue share of 14.82% in 2023. Horizon Databook has segmented the U.S. transdermal drug delivery systems market based on electroporation, radio frequency, iontophoresis, microporation, thermal, mechanical arrays, ultrasound covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to U.S. transdermal drug delivery systems market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. transdermal drug delivery systems market databook
-
Our clientele includes a mix of transdermal drug delivery systems market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. transdermal drug delivery systems market , including forecasts for subscribers. This country databook contains high-level insights into U.S. transdermal drug delivery systems market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. transdermal drug delivery systems market size, by electroporation, 2018-2030 (US$M)
U.S. Transdermal Drug Delivery Systems Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
